PT1321471E - Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico - Google Patents
Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceuticoInfo
- Publication number
- PT1321471E PT1321471E PT03290605T PT03290605T PT1321471E PT 1321471 E PT1321471 E PT 1321471E PT 03290605 T PT03290605 T PT 03290605T PT 03290605 T PT03290605 T PT 03290605T PT 1321471 E PT1321471 E PT 1321471E
- Authority
- PT
- Portugal
- Prior art keywords
- aceitable
- perindopril
- vision
- pharmaceutical
- new synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03290605A EP1321471B1 (fr) | 2003-03-12 | 2003-03-12 | Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1321471E true PT1321471E (pt) | 2005-07-29 |
Family
ID=8185877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03290605T PT1321471E (pt) | 2003-03-12 | 2003-03-12 | Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico |
Country Status (10)
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1362864T1 (sl) * | 2003-06-30 | 2007-08-31 | Servier Lab | Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli |
ES2256689T3 (es) * | 2003-06-30 | 2006-07-16 | Les Laboratoires Servier | Nuevo procedimiento de sintesis del perindopril y de sus sales farmaceuticamente aceptables. |
SI1367062T1 (sl) * | 2003-07-31 | 2006-12-31 | Servier Lab | Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli |
ES2272922T3 (es) | 2003-08-29 | 2007-05-01 | Les Laboratoires Servier | Nuevo procedimiento de sintesis de perindopril y de sus sales farmaceuticamente aceptables. |
SI1380591T1 (sl) | 2003-08-29 | 2006-02-28 | Servier Lab | Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli |
MX2008002064A (es) * | 2005-08-12 | 2008-04-17 | Lek Pharmaceuticals | Un proceso para la preparacion de perindopril-erbumina. |
WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
PH12018502155B1 (en) | 2016-04-20 | 2024-03-27 | Servier Lab | Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR78413B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1981-12-29 | 1984-09-27 | Hoechst Ag | |
FR2807431B1 (fr) * | 2000-04-06 | 2002-07-19 | Adir | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables |
FR2827860B1 (fr) * | 2001-07-24 | 2004-12-10 | Servier Lab | Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril |
-
2003
- 2003-03-12 SI SI200330035T patent/SI1321471T1/xx unknown
- 2003-03-12 DK DK03290605T patent/DK1321471T3/da active
- 2003-03-12 ES ES03290605T patent/ES2240919T3/es not_active Expired - Lifetime
- 2003-03-12 AT AT03290605T patent/ATE294814T1/de active
- 2003-03-12 PT PT03290605T patent/PT1321471E/pt unknown
- 2003-03-12 EP EP03290605A patent/EP1321471B1/fr not_active Expired - Lifetime
- 2003-03-12 DE DE60300581T patent/DE60300581T2/de not_active Expired - Lifetime
-
2004
- 2004-03-12 AR ARP040100804A patent/AR043567A1/es not_active Application Discontinuation
- 2004-03-12 WO PCT/FR2004/000594 patent/WO2004083238A1/fr active Application Filing
- 2004-03-12 MY MYPI20040880A patent/MY135359A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE60300581D1 (de) | 2005-06-09 |
DK1321471T3 (da) | 2005-08-29 |
EP1321471A1 (fr) | 2003-06-25 |
EP1321471B1 (fr) | 2005-05-04 |
AR043567A1 (es) | 2005-08-03 |
SI1321471T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2005-08-31 |
DE60300581T2 (de) | 2006-01-19 |
WO2004083238A1 (fr) | 2004-09-30 |
ES2240919T3 (es) | 2005-10-16 |
ATE294814T1 (de) | 2005-05-15 |
MY135359A (en) | 2008-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7948A (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
NO20055417D0 (no) | Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor | |
AU2003227360A1 (en) | Novel amide derivatives or salts thereof | |
CY2018005I1 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
ATE424395T1 (de) | Aminoderivate als histone-deacetylase-inhibitoren | |
KR20050009999A (ko) | 약제학적 제제 | |
DE60333020D1 (de) | Anzeigeeinrichtung des dünnen typs | |
DE602004031543D1 (de) | Amidderivate | |
DE60334100D1 (de) | Rückspiegelanordnungen | |
DK2248807T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
NO20033565L (no) | Acylerte indanylaminer og deres anvendelse som farmasöytiske midler | |
NO20054969D0 (no) | 2-cyanopropansyreamid- og esterderivater og deres anvendelse | |
NO20050830L (no) | Acylerte heteroarylkondenserte sykloalkenylaminer og deres anvendelse som farmasoytiske midler | |
DE60201859D1 (de) | Pharmazeutische Verwendung von N-Carbamoylazol-Derivate | |
NO20034970D0 (no) | Nye arylheteroalkylaminderivater | |
DK1622612T3 (da) | Farmaceutisk formulering af natriumsaltet af telmitarsan | |
DE60300011D1 (de) | Perindoprilsalz und dieses enthaltende Arzneimittel | |
ATE309789T1 (de) | Darreichungsform von ibuprofen-natrium | |
EE200200040A (et) | Ketotifeeni sisaldav oftalmiline ravimkoostis | |
HRP20150163T1 (xx) | Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina | |
PT1321471E (pt) | Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico | |
NO20030382D0 (no) | Nye indolderivater og deres anvendelse som medikamenter | |
PL361518A1 (pl) | Zastosowanie substancji oraz kompozycja farmaceutyczna | |
DE60336720D1 (de) | Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten | |
NO20054662D0 (no) | Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre |